Literature DB >> 14584858

Factors influencing the outcome of regenerative therapy in mandibular Class II furcations: Part I.

Gerald M Bowers1, Robert G Schallhorn, Pamela K McClain, Grace M Morrison, Rose Morgan, Mark A Reynolds.   

Abstract

BACKGROUND: Factors influencing the outcome of regenerative therapy of Class II furcations are incompletely and poorly understood. The purpose of this 24-month prospective study was to examine the relationship of patient-, site-, and treatment-related factors to the clinical closure of randomly selected mandibular Class II furcations. Results of therapy were evaluated at 1 and 2 years postoperatively. One-year outcome data are presented in this report.
METHODS: A total of 43 otherwise healthy individuals with chronic periodontitis (26 male, 17 female), 36 to 70 years of age, completed the 12-month evaluation of the study. Entry criteria included clinical and radiographic evidence of two or more mandibular facial Class II furcation defects (> or = 3 mm horizontal probing depth). Surgical therapy was completed by four periodontists (two each) in either a university clinic or private practice. Each patient contributed two furcation defects that were treated by combination therapy using an expanded polytetrafluoroethylene (ePTFE) membrane and demineralized freeze-dried bone allograft (DFDBA). Clinical measurements included a gingival index, plaque index, mobility, and, referencing an occlusal stent, probing depth (PD), probing attachment level-vertical (PAL-V), and probing attachment level-horizontal (PAL-H). Multiple linear measurements were recorded for each site clinically and after surgical debridement to characterize defect morphology, root configuration, and barrier placement. Defect volume was computed mathematically. Postsurgical maintenance care was provided at 1 to 2, 4, 6, and 8 weeks, and then biweekly until 3 months, with subsequent supportive periodontal maintenance visits at 3-month intervals. The clinical status of the furcation (open or closed), measured by a non-treating periodontist at 1 and 2 years, was the primary outcome measure. The association of patient-related factors (e.g., smoking), site-related factors (e.g., root configuration and defect morphology), and treatment-related factors (e.g., membrane exposure) to clinical status of furcations was assessed using random effects hierarchical logistic regression analysis, controlling for design and demographic variables. Non-parametric analysis was used for specific group comparisons.
RESULTS: Complete clinical closure was achieved in 74% of all sites. Of the residual furcation defects, 68% were reduced to Class I. No defects progressed to Class III. Significant improvements in mean PD and PAL-V were obtained following surgical therapy. Although the proportion of sites demonstrating complete furcation closure was comparable for smokers and non-smokers, the proportion of Class II residual defects was significantly higher among smokers than non-smokers (62.5% versus 14.3%, respectively). Increases in presurgical PAL-H were associated with monotonic decreases in the percentage of sites demonstrating complete clinical closure, with only 53% of lesions > or = 5 mm responding with complete closure. Similarly, significant reductions in the frequency of clinical closure were associated with increases in the distance between the roof of furcation and crest of bone, roof of furcation and base of defect, depth of horizontal defect, and divergence of roots at the crest of bone.
CONCLUSIONS: The successful clinical closure of Class II furcations was achievable at 1 year following combination therapy with an ePTFE membrane and DFDBA. The highest frequency of clinical furcation closure was observed in early Class II defects. Furcations with vertical or horizontal bone loss of 5 mm or greater responded with the lowest frequency of complete clinical closure. Nevertheless, complete furcation closure was achievable in 50% of molars with extensive bone loss. Also, 15 out of 22 (68%) of all residual defects were reduced to Class I and only seven (8%) failed to improve, demonstrating that successful clinical resolution of advanced defects remains an attainable goal.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14584858     DOI: 10.1902/jop.2003.74.9.1255

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  20 in total

1.  Antibacterial activity of chitosan-based matrices on oral pathogens.

Authors:  Aparna R Sarasam; Phoebe Brown; Sharukh S Khajotia; John J Dmytryk; Sundararajan V Madihally
Journal:  J Mater Sci Mater Med       Date:  2007-08-15       Impact factor: 3.896

Review 2.  The tobacco-using periodontal patient: role of the dental practitioner in tobacco cessation and periodontal disease management.

Authors:  Benjamin W Chaffee; Elizabeth T Couch; Mark I Ryder
Journal:  Periodontol 2000       Date:  2016-06       Impact factor: 7.589

3.  [Tooth loss and multivariable analysis after 5-year non-surgical periodontal treatment on molars with furcation involvement].

Authors:  S W Shi; Y Meng; J Jiao; W J Li; H X Meng; Q X Luan; W C Wang
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-10-18

4.  Enamel matrix protein derivative and/or synthetic bone substitute for the treatment of mandibular class II buccal furcation defects. A 12-month randomized clinical trial.

Authors:  Lucas Araujo Queiroz; Mauro Pedrine Santamaria; Marcio Z Casati; Karina Silverio Ruiz; Francisco Nociti; Antonio Wilson Sallum; Enilson A Sallum
Journal:  Clin Oral Investig       Date:  2015-11-10       Impact factor: 3.573

5.  Efficacy of MTA and CEM Cement with Collagen Membranes for Treatment of Class II Furcation Defects.

Authors:  Habib Ollah Ghanbari; Morteza Taheri; Salman Abolfazli; Saeed Asgary; Maryam Gharechahi
Journal:  J Dent (Tehran)       Date:  2014-05-31

6.  Guided tissue regeneration and platelet rich growth factor for the treatment of Grade II furcation defects: A randomized double-blinded clinical trial - A pilot study.

Authors:  Niloofar Jenabian; Sina Haghanifar; Hodis Ehsani; Ehsan Zahedi; Masumeh Haghpanah
Journal:  Dent Res J (Isfahan)       Date:  2017 Nov-Dec

7.  Mathematical analysis of furcation angle in extracted mandibular molars.

Authors:  Johnson R James; K V Arun; Avaneendra Talwar; T S S Kumar
Journal:  J Indian Soc Periodontol       Date:  2013-01

8.  Clinical and radiographic evaluation of Bio-Gen with biocollagen compared with Bio-Gen with connective tissue in the treatment of class II furcation defects: a randomized clinical trial.

Authors:  Niloofar Jenabian; Sina Haghanifar; Avideh Maboudi; Ali Bijani
Journal:  J Appl Oral Sci       Date:  2013 Sep-Oct       Impact factor: 2.698

9.  Treatment strategy for guided tissue regeneration in various class II furcation defect: Case series.

Authors:  Pushpendra Kumar Verma; Ruchi Srivastava; K K Gupta; T P Chaturvedi
Journal:  Dent Res J (Isfahan)       Date:  2013-09

Review 10.  Association between susceptible genotypes to periodontitis and clinical outcomes of periodontal regenerative therapy: A systematic review.

Authors:  G-S Chatzopoulos; V-P Koidou
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2016-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.